Author:
Tubic-Grozdanis Marija,Bolger Michael B.,Langguth Peter
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12(3):413–420 (1995),1995/03/01.
2. F. D. A. Guidance. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. US Food and Drug Administration Center for Drug Evaluation and Research (2000).
3. CPMC (EU). CPMP Note for Guidance on the Investigation of Bioavailability and Bioequivalence (CPMP/EWP/QWP/1401/98). (2001).
4. W. Preparations, G. W. H. Organization. WHO Expert Committee on Specifications for Pharmaceutical Preparations: World Health Organization (2006).
5. E. Rinaki, A. Dokoumetzidis, G. Valsami, and P. Macheras. Identification of biowaivers among class II drugs: theoretical justification and practical examples. Pharm. Res. 21(9):1567–1572 (2004).
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献